This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Conference on Cell & Stem Cell Research" (Stem Cells 2023) August 21-23, 2023 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at stem-cell@magnusconference.com or call + 1 (702) 988 2320.
Individual cells' ability to initiate all lineages of the mature organism in response to cues from the embryo or cell culture environment is known as pluripotency. A pluripotent cell is a blank slate with no preconceived program. Pluripotent stem cells have the ability to self-renew as well as generate all of the cell types that make up the three germ layers. Pluripotent stem cells were previously produced from cultures acquired from the blastocyst's interior cell mass (embryonic stem cells — ESCs). In the last few years, we've learned a lot more about the molecular mechanisms underlying pluripotency. Both transcriptional and epigenetic regulation are two fundamental mechanisms enabling pluripotency, it has become increasingly obvious.
Title : The adult stem cells and the cancer stem cells in the context of ovarian cancer
Pushpam Kumar Sinha, Independent Researcher, India
Title : Cell based therapies in articular cartilage repair
Anjali Goyal, NHL Municipal Medical College, India
Title : Comparative study on the effect of adipose-derived stem cells versus alpha-lipoic acid inautologus fat graft survival
Sahar Mohamed Mahdy Omar, Ain Shams University, Egypt
Title : Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
Asma Alanazi, King Saud Bin Abdulaziz University, Saudi Arabia
Title : Stem cell therapy in radiotherapy from bench to clinical trial evaluating the efficacy of Mesenchymal stromal cell injections for the treatment of chronic pelvic complications induced by radiation therapy
Alain chapel, Institute of Radiological Protection and Nuclear Safety, France
Title : Optimized protocol for generating clinical grade umbilical cord tissue mesenchymal stem cell for cell therapy in various disease
Rekha Kumari, Institute of Liver and Billiary Sciences, India